Synlogic gets Ginkgo Bioworks’ help to launch T. rex inspired synthetic biotic for gout
Synlogic, Inc. has announced a new drug candidate for the treatment of gout developed in…
August 11, 2022 - 2 minutes
Kidney disease
Enrollment completed for trial looking at treatment of diabetic kidney disease
Enrollment has been completed for a study of a regenerative cell therapy investigational product for…
August 2, 2022 - 2 minutes
Positive news for Aurinia’s voclosporin drug Lupkynis to treat lupus nephritis
British Columbia-based Aurinia Pharmaceuticals Inc. announced today (July 22) that its voclosporin drug has been…
July 22, 2022 - 3 minutes
ZyVersa Therapeutics and Larkspur merge to become publicly traded biopharma company
U.S. biopharma company ZyVersa Therapeutics, Inc., and Larkspur Health Acquisition Corp., a blank-check special purpose…
July 21, 2022 - 3 minutes
Spanish company, 3P Biopharmaceuticals, manufactures biomass to treat black fungus
A biomass to treat a difficult and evasive fungal infection with a high mortality rate…
July 12, 2022 - 3 minutes
Farxiga’s Approval Fuels Chronic Kidney Disease Comeback
Until this year, there were no effective treatments for chronic kidney disease. However, the recent…
June 8, 2021 - 5 minutes
Update: AM-Pharma Increases Acute Kidney Injury Phase III Funds to €163M
Update (31/03/2020): AM-Pharma has raised an extra €47M on top of an existing €116M equity…
March 31, 2020 - 3 minutes
Immune Marker in Blood May Predict Kidney Transplant Rejection Risk
French researchers have found that the levels of certain immune cells in the blood of…
March 13, 2020 - 3 minutes
Why Communication is Key for Getting Ahead in Biotech
Many biotech founders and executives look to VC investors for advice and inspiration, but the…
September 18, 2019 - 11 minutes
€43M Series C to Launch UK Company’s Home Hemodialysis Kit
Quanta Dialysis Technologies has raised €43.2M ($48M) to fund the commercial launch of a device…
July 29, 2019 - 2 minutes
Update: Hansa Biopharma Applies for EMA Market Approval for Kidney Transplant Drug
Update (01/03/2019): Hansa Biopharma (previously named Hansa Medical) has filed an application for marketing authorization for imlifidase with…
March 1, 2019 - 3 minutes
Genetic Testing Improves Success of Kidney Transplants
Genetic variations in cell surface proteins are able to predict kidney transplant success, shows Austrian research,…
February 15, 2019 - 2 minutes
